Zero revenue is disturbing and I would be cautious as an investor here, but I do think CBIS has the potential to come up with a drug and that could get them rolling. However, so far all they've added are directors and some research. CBIS is a possible takeover candidate if they actually come up with something, but they're now nearing $100 million lost since starting.
News 
Market Data 
Discover 
AI
